Novocure
Dheeraj Bhavanasi, Ph.D., BCMAS, currently serves as a Medical Science Liaison at Novocure since November 2022, following a similar role at Acrotech Biopharma, LLC from October 2021 to November 2022. Prior experience includes a position as a Scientist and KellyOCG Site Operations Manager at The Janssen Pharmaceutical Companies of Johnson & Johnson, where responsibilities encompassed managing a functional genomics team and developing in vitro lung cancer models. Dheeraj's research background features a postdoctoral position at the University of Pennsylvania, focusing on drug screening methods for hematological diseases, and a graduate research assistant role at Temple University, concentrating on platelet physiology. Educational qualifications include a Ph.D. in Platelet Physiology from Temple University and a Master's degree in Biotechnology from the University of Hyderabad.
This person is not in any offices
Novocure
3 followers
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure’s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma.